Continued Pressure for Alveolar Protection (CPAP Trial)
Start Date
11/5/2026
Completion Date
1/30/2029
Summary
The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
CPAP
Nasal Cannula
Conditions
Locations
University of Alabama at Birmingham
Birmingham, Alabama 35233
United States
Stanford University
Palo Alto, California 94304
United States
Sharp Mary Birch Hospital for Women & Newborns
San Diego, California 92123
United States
Emory University
Atlanta, Georgia 30303
United States
Northwestern Lurie Children's Hospital of Chicago
Chicago, Illinois 60611
United States
University of Iowa
Iowa City, Iowa 52242
United States
University of Mississippi Medical Center - Children's of Mississippi
Jackson, Mississippi 39216
United States
University of New Mexico
Albuquerque, New Mexico 87131
United States
Duke University
Durham, North Carolina 27710
United States
Cincinnati Children's Medical Center
Cincinnati, Ohio 45267
United States
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio 44106
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas 75235
United States
University of Texas Health Science Center at Houston
Houston, Texas 77030
United States
University of Utah
Salt Lake City, Utah 84108
United States